课题基金 / 基金详情

REGULATION OF APOPTOSIS BY NOS

REGULATION OF APOPTOSIS BY NOS
NOS 对细胞凋亡的调节
批准号:
2900931
负责人:
JOAN B MANNICK
金额:
$11.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2000-03-31

项目摘要

项目成果

JOAN B MANNICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Investigator's abstract): Nitric oxide (NO) is a small, highly reactive gas synthesized by the enzyme NO synthase (NOS). NOS activity in murine leukocytes has been shown to play an important role in the murine immune response. However, the role of NOS in the human immune system remains highly controversial because NOS-associated effects in human leukocytes have been very difficult to demonstrate. Our preliminary data indicate that very low levels of NOS expressed constitutively in human lymphocyte or monocyte-derived cells lines regulate apoptosis. We hypothesize that NOS activity regulates apoptosis in human primary lymphocytes and/or monocytes as well as in cell lines, and therefore, that NOS activity has a physiologically relevant role in the human immune system. In Specific Aim 1, we will test this hypothesis by determining if NOS-activity in human primary lymphocytes and monocytes regulates spontaneous or Fas-induce apoptosis. In Specific Aim 2, human lymphocytic cell lines will be used as models to investigate the mechanism by which NOS inhibits Fas-induced apoptosis. Our hypothesis is that NOS activity inhibits Fas-induced apoptosis at the level of Fas-associated protein complex formation. The proposed studies will contribute ot the immunology and nitric oxide fields. The studies will clarify whether NOS activity has a physiologic role in the human as well as the murine immune system: will provide insight into the mechanism by which NOS activity exerts biological effects in human cells; and will elucidate a novel NOS-dependent regulation of Fas-induced apoptosis. Ultimately these studies may lead to the development of NO-based therapies to treat disorders associated with dysregulation of apoptosis including autoimmune diseases, cancer and the acquired immunodeficiency syndrome.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1083/jcb.200104008
发表时间: 2001-09-17
期刊: The Journal of cell biology
影响因子: --
作者: [Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K, Gaston B]
通讯作者: Gaston B
Pilot study of RTB101 as COVID-19 prophylaxis in older adults with amended research plan and budget
  • 批准号:
    10254578
  • 项目类别:
  • 资助金额:
    $5.13万
  • 财政年份:
    2019
  • 负责人:
    JOAN B MANNICK
  • 依托单位:
mTOR Regulation of Basal Antiviral Immunity in the Elderly
  • 批准号:
    10474737
  • 项目类别:
  • 资助金额:
    $29.24万
  • 财政年份:
    2019
  • 负责人:
    JOAN B MANNICK
  • 依托单位:
Pilot study of RTB101 as COVID-19 prophylaxis in older adults
  • 批准号:
    10170919
  • 项目类别:
  • 资助金额:
    $65.96万
  • 财政年份:
    2019
  • 负责人:
    JOAN B MANNICK
  • 依托单位:
Depletion of Mitochondrial S-Nitrosothiols in ALS
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: